Chemiesynth (Vapi) Ltd

Chemiesynth (Vapi) Ltd

Chemiesynth (Vapi) Ltd has submitted its unaudited financial results for the first quarter ended June 30, 2026. The Board of Directors has approved the results and also considered and approved several other matters, including increasing the authorized share capital, adopting a new set of Articles of Association, and issuing unlisted non-convertible cumulative redeemable preference shares (NCRPS) on a private placement basis.

Chemiesynth (Vapi) Ltd

Chemiesynth (Vapi) Ltd's board meeting outcome: approved un-audited financial results for Q2 2026, increased authorized share capital, and issued unlisted non-convertible redeemable preference shares (NCRPS) on a private placement basis.

Chemiesynth (Vapi) Ltd

Chemiesynth (Vapi) Ltd has scheduled a Board Meeting on 12/08/2026 to consider and approve standalone unaudited financial results for the quarter ended 30th June, 2026.